Drug
Pro044
Pro044: highest development phase Phase 1/2, developed by BioMarin Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| PRO044 SC NCT01037309 | Phase 1/2 | Duchenne Muscular Dystrophy |
Latest
No recent events.
Follow Pro044 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.